• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Bugs in the system

tetano

Editor, Senior Moderator
Immunol Rev. 2013 Sep;255(1):256-74. doi: 10.1111/imr.12092.
Bugs in the system.
Menachery VD, Baric RS.
Source

Department of Epidemiology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Abstract

Immunity to respiratory virus infection is governed by complex biological networks that influence disease progression and pathogenesis. Systems biology provides an opportunity to explore and understand these multifaceted interactions based on integration and modeling of multiple biological parameters. In this review, we describe new and refined systems-based approaches used to model, identify, and validate novel targets within complex networks following influenza and coronavirus infection. In addition, we propose avenues for extension and expansion that can revolutionize our understanding of infectious disease processes. Together, we hope to provide a window into the unique and expansive opportunity presented by systems biology to understand complex disease processes within the context of infectious diseases.

? 2013 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
KEYWORDS:

H1N1, H5N1, MERS-CoV, SARS-CoV, coronavirus, influenza, systems biology

PMID:
23947361
[PubMed - in process]

http://www.ncbi.nlm.nih.gov/pubmed/23947361
 
Back
Top Bottom